|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 505 KING AVENUE |
Address2 |
|
City | COLUMBUS |
State | OH |
Zip Code | 43201-2693 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 5585-12
|
||||||||
|
6. House ID# 302170000
|
TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Paul T. Doucette |
Date | 1/22/2025 12:51:47 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 8997; S.4927; Energy and Water Development and Related Agencies Appropriations Bill, 2025; Title III, Department of Energy, all provisions and issues relating to the Department of Energy, and its science, energy, and national security programs.
H.R. 9026; S.4795; Commerce, Justice, Science and Related Agencies Appropriations Bill, 2025; National Science Foundation, Research and Related Activities; FBI, provisions related to biodefense lab operations.
H.R. 8774; S. 4921; Defense Appropriations Bill, 2025; Issues and provisions related to Title II - O&M; Title III - Procurement; Title IV - RDT&E, Title VI - Defense Health, and the Military and National Intelligence programs.
H.R. 8752; Draft Senate Bill; Department of Homeland Security Appropriations Bill, 2025; Science and Technology Directorate, all issues related to laboratory facilities, and research, development, acquisition, and operations; issues related to BioWatch and BD21; issues related to chemical and biological readiness. TSA Security Equipment Maintenance. Countering Weapons of Mass Destruction Office, issues related to biological defense; USCG O&M.
H.R. 9029; S. 4942; Labor, HHS Appropriations Bill 2025; Issues related to HHS; pandemic preparedness, vaccines; CDC, gene synthesis screening.
H.R. 8998; S. 4802; Interior & Environment Appropriations Bill 2025; Issues related to PFAS destruction and destruction verification methods.
Issues related to the Administration's Fiscal Year 2025 budget request for the Department of Energy and its science, energy, environmental management, and national security programs.
Issues related to the Administration's Fiscal Year 2026 budget request for the Department of Energy and its science, energy, environmental management, and national security programs.
Issues related to implementation of the CHIPS and Science Act.
Issues related to vaccines, genomic sequencing; medical countermeasures, pandemic preparedness and response.
Issues related to infrastructure spending: PFAS remediation; I-ARPA.
Issues related to Biosecurity.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Energy - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Doucette |
|
|
|
Jeffrey |
Rose |
|
|
|
Heather |
Hescheles |
|
|
|
Aaron |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
H.R. 8070; S. 4638; National Defense Authorization Act for Fiscal Year 2025; Issues and provisions related to Title II - O&M; Title III - Procurement; Title IV - RDT&E, Title VI - Defense Health, the Military and National Intelligence programs and environmental restoration and PFAS destruction Technology; Title XXXI DOE National Security Programs.
H.R. 8512; S. 4443; Intelligence Authorization Act for FY25; Intelligence Activities including cyber, microelectronics, biotechnology, biopreparedness, biosecurity, research security and intelligence matters relating to China.
Draft Bills; Defense Appropriations Bill, 2025; Issues and provisions related to Title II - O&M; Title III - Procurement; Title IV - RDT&E, Title VI - Defense Health, and the Military and National Intelligence programs.
S. 3799; PREVENT Pandemics Act; Biosecurity; Biopreparedness; Biotechnology; Congressionally Directed Medical Research Program; Spinal Cord Injury Research Program; Neurotechnology
S. 3558; H.R. 7085; A bill to prohibit contracting with certain biotechnology providers, and for other purposes.; All titles and sections.
Issues related to NNSA weapons and nonproliferation programs.
Issues related to Semiconductor / Microelectronics Manufacturing and Research; implementation of CHIPS and Science Act.
Issues related to military health and rehabilitation; veteran rehabilitation; neurotechnology.
Issues related to Biosecurity.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Doucette |
|
|
|
Jeff |
Rose |
|
|
|
Heather |
Hescheles |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Draft Bill; Combining Laboratory Expertise to Accelerate Novel Solutions for Minimizing Accumulated Radioactive Toxins (CLEAN SMART) Act of 2024; All titles and sections.
Issues related to Department of Energy Office of Fossil Energy
Issues related to Department of Energy technology transfer and commercialization policies and activities.
Issues related to smart grid, energy storage and electricity cybersecurity funding, programs, facilities and initiatives.
Issues related to biological and environmental research, and climate programs and laboratories.
Issues related to DOE's renewable energy, energy efficiency, nuclear energy and fossil energy R&D programs.
Issues related to the Administration's Fiscal Year 2024 and 2025 budget request for the Department of Energy and its science, energy, environmental management, and national security programs.
Issues related to national laboratory facilities and infrastructure funding, financing, and operations.
Issues related to R&D in support of cleanup and nuclear security missions.
Issues related to DOE Environmental Management Programs
Issues related to research security.
Rulemaking; Hydrogen and Fuel Cell R&D Issues related to DOE Hydrogen R&D programs and roll out.
Rulemaking; Hydrogen 45V; Issue related to Hydrogen tax credit.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Energy - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Doucette |
|
|
|
Jeff |
Rose |
|
|
|
Aaron |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
H.R. 9671, S. 4664; Department of Energy Artificial Intelligence Act of 2024; All titles and sections.
S. 4932; Department of Energy Quantum Leadership Act; All titles and sections.
H.R. 6213; National Quantum Initiative Reauthorization Act; All sections pertaining to DOE.
Issues related to the Department of Energy Office of Science funding, programs, facilities, and initiatives.
Issues related to nuclear physics research and facilities and isotope production.
Issues related to Department of Energy technology transfer and commercialization policies and activities.
Issues related to federal funding for basic scientific research.
Issues related to Department of Energy supercomputing, quantum information sciences.
Issues related to artificial intelligence/machine learning.
Issues related to fusion energy research and international collaborations.
Issues related to national laboratory facilities and infrastructure funding, financing, and operations.
Issues related to biomanufacturing, biosecurity; biopreparedness.
Issues related to Neurotechnology.
Issues related to NSF; R&D and Innovation investments.
Issues related to Semiconductor / Microelectronic manufacturing and research.
Issues related to research security.
Issues related to implementation of the CHIPS and Science Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Energy - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Doucette |
|
|
|
Heather |
Hescheles |
|
|
|
Jeff |
Rose |
|
|
|
Aaron |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
H.R. 8752, Draft Senate Bill; Department of Homeland Security Appropriations Bill, 2025; Issues related to DHS Science and Technology Directorate chem-bio defense mission and laboratory operations, research, and infrastructure; TSA TSL and Procurement, Construction and Improvements; Countering Weapons of Mass Destruction Office issues related to R&D and biodefense; Biowatch and BD21 programs
S.1210, H.R. 2791; National Biodefense Analysis and Countermeasures Center Authorization Act of 2023; All titles and sections.
S. 3558; H.R. 7085; A bill to prohibit contracting with certain biotechnology providers, and for other purposes.; All titles and sections.
Issues related to CWMD; BD21.
Issues related to DHS S&T Directorate.
Issues related to laboratory facilities and infrastructure.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Doucette |
|
|
|
Jeff |
Rose |
|
|
|
Heather |
Hescheles |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 3799 (117th); Implementation of "PREVENT Pandemics" Act; Issues related to pandemic prevention; testing; surveillance.
H.R. 9029; Draft Senate Bill; Labor, HHS Appropriations Bill 2025; Issues related to HHS; pandemic preparedness, vaccines; gene synthesis screening; CDC.
Draft Bills; Pandemic All Hazardous Prevent Act (PAHPA); Issues related to MCM PRV; Gene Synthesis Screening.
Draft Bills; Securing Gene Synthesis Act; Issues related to gene synthesis products and screening
S. 3558; H.R. 7085; A bill to prohibit contracting with certain biotechnology providers, and for other purposes.; All titles and sections.
Issues related to COVID-19 testing and vaccine studies; Vaccine durability and efficacy; genomic sequencing; medical countermeasures; autoinjectors; pandemic preparedness and response.
Issues related to CDC authorization and appropriations;Consensus Based Entity.
Issues related to military health and rehabilitation (neurotechnology).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeff |
Rose |
|
|
|
Heather |
Hescheles |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
Draft bill; PFAS Authorization bill; Authorization bill to address PFAS issues.
H.R. 8998; Draft Senate Bill; Interior & Environment Appropriations bill for FY25; Issues Related to PFAS destruction and destruction verification methods.
Draft Bill; Combining Laboratory Expertise to Accelerate Novel Solutions for Minimizing Accumulated Radioactive Toxins Act of 2024; All titles and sections.
Issues related to groundwater remediation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeffrey |
Rose |
|
|
|
Heather |
Hescheles |
|
|
|
Paul |
Doucette |
|
|
|
Aaron |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INT
16. Specific lobbying issues
H.R. 8512; S.4443; Intelligence Authorization Act for FY25; Intelligence Activities including cyber, microelectronics, biotechnology, biopreparedness, biosecurity, research security, and intelligence matters relating to China.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Heather |
Hescheles |
|
|
|
Paul |
Doucette |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |